KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Emergent BioSolutions (EBS) Asset Utilization Ratio (2016 - 2025)

Historic Asset Utilization Ratio for Emergent BioSolutions (EBS) over the last 17 years, with Q3 2025 value amounting to 0.55.

  • Emergent BioSolutions' Asset Utilization Ratio fell 1095.48% to 0.55 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.55, marking a year-over-year decrease of 1095.48%. This contributed to the annual value of 0.65 for FY2024, which is 5445.22% up from last year.
  • Latest data reveals that Emergent BioSolutions reported Asset Utilization Ratio of 0.55 as of Q3 2025, which was down 1095.48% from 0.6 recorded in Q2 2025.
  • Over the past 5 years, Emergent BioSolutions' Asset Utilization Ratio peaked at 0.65 during Q1 2024, and registered a low of 0.32 during Q1 2023.
  • Moreover, its 5-year median value for Asset Utilization Ratio was 0.56 (2023), whereas its average is 0.55.
  • Per our database at Business Quant, Emergent BioSolutions' Asset Utilization Ratio crashed by 4612.57% in 2023 and then soared by 10460.74% in 2024.
  • Emergent BioSolutions' Asset Utilization Ratio (Quarter) stood at 0.61 in 2021, then tumbled by 39.45% to 0.37 in 2022, then skyrocketed by 53.16% to 0.56 in 2023, then grew by 3.61% to 0.59 in 2024, then dropped by 6.31% to 0.55 in 2025.
  • Its Asset Utilization Ratio stands at 0.55 for Q3 2025, versus 0.6 for Q2 2025 and 0.54 for Q1 2025.